Since the discovery of mammalian BIK and BAD in 1995, BH3-only proteins have emerged as key activators of apoptotic cell death in animals as diverse as the nematode, Caenorhabditis elegans, and humans. BH3-only proteins have also emerged as integrators of cell-death signals that determine the life-versus-death decision and that transduce this decision to the central apoptotic machinery through their physical interaction with 'core' BCL-2 family members, such as BCL-2 or BCL-XL. Currently, eight BH3-only proteins have been identified and characterized in mammals, and there is evidence of functional overlap between them. In contrast, only two BH3-only proteins have so far been identified and characterized in C. elegans, EGL-1 and CED-13, and there seems to be only limited functional overlap between them. Combined with the powerful genetic tools available for the analysis of apoptosis in C. elegans, and the ability to study apoptosis at single-cell resolution in this organism, the absence of extensive functional redundancy makes C. elegans an ideal model for studies on BH3-only proteins. In this study, we will review our current understanding of the role and regulation of EGL-1. We will also briefly summarize studies on CED-13, which was identified more recently.
The egl-1 story
The egl-1 gene was originally defined by dominant, gain of function (gf) mutations (Trent et al., 1983; Ellis and Horvitz, 1986) . These gf mutations cause the hermaphrodite-specific neurons (referred to as 'HSNs'), which are required for egg laying in Caenorhabditis elegans hermaphrodites, to inappropriately die. egl-1 gf mutations were identified in screens for egg-laying defective or 'Egl' animals, and were carried out in Bob Horvitz's laboratory in the early 1980s (hence the name 'egl-1'). These 'Egl screens' resulted in the identification of a total of seven egl-1 gf mutations. Three of these mutations (n487, n1084 and n1796) cause an Egl phenotype in a semi-dominant manner, and the remaining four mutations (n986, n987, n2164 and n2248) cause an Egl phenotype in a fully dominant manner. The inappropriate death of the HSNs in egl-1 gf mutants can be suppressed by mutations that cause a general block in apoptotic cell death, such as a gf mutation in ced-9, which encodes an anti-apoptotic BCL-2-like protein, or loss-of-function (lf) mutations in either ced-4 or ced-3, which encode an APAF-1-like adapter or a caspase, respectively (Ellis and Horvitz, 1986; Hengartner et al., 1992; Yuan and Horvitz, 1992; Yuan et al., 1993; Hengartner and Horvitz, 1994b) . These findings showed that the HSNs in egl-1 gf animals inappropriately die by apoptosis. They also suggested that the egl-1 gene may act upstream of the anti-apoptotic gene, ced-9, and of the pro-apoptotic genes, ced-4 and ced-3; however, the normal function of egl-1 remained unclear because of the lack of egl-1 lf mutations. The lack of egl-1 lf mutations not only made it difficult to determine the normal function of egl-1 but also to clone the gene and determine its identity. Using the gf mutations, the egl-1 gene could be mapped to a region on the right arm of linkage group V, but the gene could not be cloned using standard technology, such as transformation rescue experiments. To identify lf mutations in the egl-1 gene, reversion screens were carried out using semi-dominant alleles. Specifically, animals homozygous for a semidominant allele were mutagenized and their progeny (F1 generation) was screened for 'non-Egl' animals with wild-type egg-laying behavior. It was shown that B30% of animals trans-heterozygous for a semi-dominant egl-1 gf mutation and a deficiency that physically removes the egl-1 locus on the right arm of linkage group V were non-Egl. The rationale for the reversion screens therefore was that if the mutagenesis results in a second hit in the egl-1 locus, which causes the inactivation of the gene (that is, an egl-1 lf mutation), an animal carrying such a mutation should be detectable in the F1 generation with an B30% chance. Initially, however, egl-1 lf mutations remained elusive and it took several tries and the screening of many thousands of F1 animals for the n3082 mutation to be identified in the background of egl-1 (n1084gf). n3082, mapped to the same region on linkage group V, behaved in a manner similar to an egl-1 lf mutation and, as described below, indeed turned out to be a lf mutation in the gene (Conradt and Horvitz, 1998) .
As a result of HSN survival, similar to wild-type animals, egl-1 (n1084 n3082) animals were 100% non-Egl. However, in contrast to wild-type animals, egl-1(n1084 n3082) animals had a major defect in developmentally programed, apoptotic cell death. Similar to a gf mutation in ced-9 or to lf mutations in ced-4 or ced-3, egl-1(n1084 n3082) causes a general block in apoptotic cell death (referred to as a 'Ced' phenotype) during development, resulting in animals in which many cells that normally die, survive. Therefore, the normal function of the egl-1 gene was determined to be required for apoptotic cell death (Conradt and Horvitz, 1998) . As mentioned above, using the egl-1 gf mutations, it had already been shown that egl-1 might act upstream of ced-9, ced-4 and ced-3. This notion was supported by the finding that, unlike lf mutations of ced-4 or ced-3, which act downstream of ced-9, egl-1(n1084 n3082) fails to block ectopic apoptosis caused by the loss of ced-9 function. Using the recessive Ced phenotype caused by egl-1(n1084 n3082), the egl-1 gene could now also be cloned using transformation rescue experiments. A 7.8 kb DNA fragment was identified that rescues almost 90% of the developmental cell death events in an egl-1(n1084 n3082) background. Furthermore, a 2.5 kb subclone of this fragment still rescues about 6% of these cell death events. This subclone contains one small transcription unit with three exons and two potential initiator codons, potentially encoding a small protein of 106 or 91 amino acids. The introduction of a frameshift between the first and second initiator codon does not affect rescuing activity, which supports the notion that the more 3 0 ATG is used in vivo and that the endogenous protein hence is composed of 91 aa. (Owing to the lack of an antibody that recognizes the endogenous protein, the molecular weight of EGL-1 in vivo has so far not been determined.) The size of the gene explained why egl-1 lf mutations had been elusive for a long time and, for example, were not recovered in the screens that led to the isolation of the lf mutations in ced-4 and ced-3 (Ellis and Horvitz, 1986) . Compared with genes of average size, small genes represent smaller physical targets for mutagens and therefore are less likely to be mutated (Anderson, 1995) .
Searches of nucleotide and protein databases showed no genes or proteins with significant homology to the egl-1 gene or to the EGL-1 protein. However, matrix alignments between the EGL-1 protein and core BCL-2 family members or the newly discovered mammalian BH3-only proteins BIK, BAD, BID and HRK (harakiri) showed very limited, but significant, sequence similarity. This similarity was confined to amino acids 58-66 of the EGL-1 protein and to the BH3 domain of core BCL-2 family members and BH3-only proteins. The egl-1 lf mutation, n3082, was found to be a five-base-pair deletion, just 5 0 of the sequences that encode the BH3 domain of the EGL-1 protein, predicted to result in a frameshift and in the formation of a truncated EGL-1 protein lacking the BH3-domain. What was known about BH3-only proteins at that time? BIK, BAD, BID and HRK had all been identified on the basis of their ability to physically interact with core BCL-2 family members and they had been shown to cause apoptotic cell death when overexpressed (Boyd et al., 1995; Yang et al., 1995; Han et al., 1996; Wang et al., 1996; Inohara et al., 1997) . Similar to mammalian BH3-only proteins, EGL-1 was also found to physically interact with the C. elegans core BCL-2 family member, CED-9, through its BH3 domain. Furthermore, the overexpression of EGL-1 in C. elegans caused ectopic cell death, which was suppressed by a ced-9 gf mutation or lf mutations in ced-4 or ced-3. Combined, these results showed that C. elegans EGL-1 was a member of the family of BH3-only proteins. The egl-1 gene was the first BH3-only gene that was defined by lf mutations. The fact that its lf phenotype was a general block in apoptotic cell death during development showed that, at least in C. elegans, BH3-only proteins have a physiological role in apoptosis (Conradt and Horvitz, 1998) .
EGL-1's mechanism of action: getting down to it When raised at 22 1C, the embryonic development of C. elegans, from the first cell division to hatching, proceeds within B800 min (Sulston et al., 1983) . Of the 131 cell death events that take place in somatic tissues during development, 113 occur between 220 and 620 min of embryonic development. (The remaining 18 cell deaths take place during post-embryonic development (Sulston and Horvitz, 1977) .) At least during these B400 min, the presence of the CED-4 protein and the expression of the ced-3 gene do not seem to be restricted to the 113 cells that are programed to die (Chen et al., 2000; Maurer et al., 2007) . (Antibodies that detect endogenous proCED-3 or CED-3 protein in C. elegans have so far not been described.) This observation suggests that many cells in the developing embryo have the potential to undergo apoptosis during the embryonic wave of cell death. Similar to CED-4, and most probably to proCED-3, the anti-apoptotic CED-9 protein is present in many cells at this stage (Chen et al., 2000) . CED-9 localizes to the outer mitochondrial membrane, and it is through the physical interaction between CED-9 and an asymmetric dimer of CED-4 that the ability of CED-4 to form an active apoptosome and to mediate proCED-3 activation is blocked (Spector et al., 1997; Chinnaiyan et al., 1997b; Wu et al., 1997b; Chen et al., 2000; Yan et al., 2005) . In the 113 cells that are programed to die, this block is released by the EGL-1 protein. Specifically, EGL-1 binds to a surface area of the CED-9 protein ('EGL-1-binding site') which is distinct from the surface area of CED-9 required for its ability to interact with CED-4 dimers ('CED-4-binding site'). The interaction of EGL-1 with CED-9/ CED-4 complexes induces a dramatic structural change in CED-9, which alters its CED-4-binding site and results in the release of the CED-4 dimer (Conradt and Horvitz, 1998; del Peso et al., 1998 del Peso et al., , 2000 Chen et al., 2000; Yan et al., 2004) . CED-4 dimers released from the mitochondria-localized EGL-1/CED-9 complex relocalize to perinuclear membranes and assemble into active apoptosomes (which most probably are homotetramers), capable of mediating proCED-3 activation (Irmler et al., 1997; Seshagiri and Miller, 1997 Yan et al., 2005) . Once activated, the mature CED-3 caspase induces processes that result in the demise of the cell. Much of the mechanistic insight into this step of apoptosis induction in C. elegans is based on structural studies carried out by Ding Xue, Yigong Shi et al. (Yan et al., 2004 (Yan et al., , 2005 , who solved the crystal structure of CED-9 bound to either CED-4 or part of EGL-1. With a 100 different complexes and over 30 000 crystallization conditions, obtaining crystals of the EGL-1/CED-9 complex required a heroic effort, but resulted in the discovery of fascinating clues regarding the molecular mechanisms involved in apoptosis induction in C. elegans.
The ability of EGL-1 to initiate CED-3 activation, and hence apoptosis, by binding to CED-9, thereby causing CED-4 release, is also referred to as the 'direct' pathway of apoptosis induction (Figure 1 ) (Rolland and Conradt, 2006) . However, the release of CED-4 from CED-9 might not be the only consequence of EGL-1 binding to CED-9 with respect to apoptosis induction. It has recently been shown that EGL-1 also induces mitochondrial fragmentation, a phenomenon that is observed in apoptotic cells in many species, including the fruitfly Drosophila melanogaster and humans (Herzig and Martinou, 2008; Suen et al., 2008) . EGL-1-induced mitochondrial fragmentation depends on the function of the ced-9 gene and is mediated by the dynamin-related GTPase, DRP-1, which is required for mitochondrial fission (Labrousse et al., 1999; Jagasia et al., 2005) . DRP-1 has pro-apoptotic activity and can cause CED-4-and CED-3-dependent apoptosis when overexpressed. How DRP-1 promotes CED-4-and CED-3-dependent apoptosis remains to be determined, but recent evidence suggests that it may do so independently of its ability to cause mitochondrial fission (S Rolland, Y Lu and B Conradt; unpublished observation). On the basis of these observations, it has been proposed that another consequence of EGL-1 binding to CED-9 with respect to apoptosis induction is the EGL-1-and CED-9-dependent activation of the pro-apoptotic function of DRP-1 (Jagasia et al., 2005) . In this EGL-1-induced 'indirect' pathway of apoptosis induction, CED-9 is predicted to have a pro-apoptotic function in cells programed to die (that is, cells in which EGL-1 is bound to CED-9) (Figure 1 ). Elegant genetic experiments performed by Michael Hengartner in Bob Horvitz's laboratory have already shown that the loss of ced-9 function in cells programed to die makes these cells less likely to die, thereby providing additional experimental evidence for a pro-apoptotic function of CED-9 (Hengartner and Horvitz, 1994a) . Finally, as mammalian Bax has been shown to cause Drp1-dependent mitochondrial fragmentation in apoptotic cells as well, the EGL-1/CED-9 complex may be functionally equivalent to activated Bax (Desagher and Martinou, 2000; Frank et al., 2001) . (CED-9 is the only C. elegans member of the core BCL-2 family. There is no evidence for a BAX-like molecule in C. elegans (Consortium, 1998) .)
Controlling EGL-1 activity: transcriptional regulation is key
The sexually dimorphic HSN and CEM neurons: male or hermaphrodite?
The identification of the molecular lesions in egl-1 gf animals showed that transcriptional control is an important mechanism through which EGL-1 activity is regulated. The seven egl-1 gf mutants were found to each contain a single base change in a small motif B5.6 kb downstream of the stop codon of the egl-1 transcription unit (Conradt and Horvitz, 1999) . These single base changes alter the function of egl-1 in cis, which shows that they affect the transcription and hence the expression of the gene. The small motif affected by these mutations is highly similar to the core sequence of the GLI-like zinc-finger transcription factor, TRA-1, of C. elegans (Zarkower and Hodgkin, 1993) . TRA-1 is the terminal, global regulator of somatic sexual fate in C. elegans and it promotes female development (Zarkower, 2006) . But what does TRA-1 have to do with apoptosis regulation? The HSNs, which inappropriately die by apoptosis in egl-1 gf hermaphrodites, are actually sexually dimorphic (Sulston and Horvitz, 1977; Sulston et al., 1983) . Furthermore, they are sexually dimorphic as a result of apoptotic cell death. More specifically, the HSNs are generated B400 min after the first cell division in both males and hermaphrodites, but are eliminated again in males by apoptosis at B470 min. Using a transcriptional reporter, it was shown that the egl-1 gene is expressed in a sex-specific manner in the HSNs, with expression being detected in the HSNs in males, but not in hermaphrodites (Conradt and Horvitz, 1999) . Furthermore, this sex-specific expression was disrupted by the introduction into the reporter construct of the egl-1 gf mutations, which resulted in a detectable expression in both males and hermaphrodites. Finally, TRA-1 protein was shown to bind in vitro to the potential TRA-1-binding site, as found downstream of the egl-1 transcription unit in wild-type animals. In contrast, TRA-1 failed to bind to the site after the introduction of one of the dominant egl-1 gf mutations and it bound with much reduced affinity to the site after the introduction of one of the semi-dominant egl-1 gf mutations. On the basis of these observations, it was proposed that, in hermaphrodites in which TRA-1 is active, TRA-1 binds to the TRA-1-binding site downstream of the egl-1 transcription unit and thereby antagonizes the activity of an HSN-specific transcriptional activator of egl-1, resulting in the repression of egl-1 transcription and in HSN survival (Figure 2 ) (Conradt and Horvitz, 1999) . (The involvement of an HSN-specific activator is proposed, because TRA-1 is ubiquitiously expressed, but only affects the deaths of the HSNs and CEMs (see below).) Conversely, in males in which TRA-1 is not active, the HSN activator can mediate the transcriptional activation of egl-1, resulting in egl-1 transcription and HSN death. In egl-1 gf hermaphrodites, TRA-1 is active, but unable to bind to the mutant TRA-1-binding site. As in males, this allows the HSN activator to mediate egl-1 transcriptional activation, resulting in the inappropriate death of the HSNs. Finally, the egl-1 lf mutation, n3082, completely blocks the inappropriate death of the HSNs in egl-1(n1084gf) hermaphrodites. As mentioned above, n3082 results in the synthesis of a truncated EGL-1 protein, which lacks the BH3 domain and is unable to initiate apoptosis. The identity of the HSN activator remains to be determined. However, co-repressor complexes have been identified which co-operate with TRA-1 to repress egl-1 transcription in the HSNs. Specifically, a complex composed of the PLZF (promyelocytic leukemia zinc finger protein)-like zinc-finger transcription factor, TRA-4, the histone deacetylase, HDA-1, and the histone chaperone, NASP-1, as well as the DRM (DRM, DP, Rb and MuvB) complex are required for efficient TRA-1-dependent repression of egl-1 transcription in the HSNs in hermaphrodites (Grote and Conradt, 2006; Harrison et al., 2006; Large and Mathies, 2007) . Both complexes have been implicated in chromatin remodeling, which indicates that epigenetic gene regulation plays a critical role in the control of egl-1 transcription. Recent evidence from Bob Horvitz's laboratory suggests that the transcription of genes encoding components of the central cell-death pathway, other than EGL-1 (that is, CED-9, CED-4 or CED-3), may also be under the control of epigenetic gene regulation (Reddien et al., 2007) . egl-1: a key activatorSimilar to HSNs, the four CEM (cephalic companion neurons) neurons, which have been implicated in pheromone perception, are sexually dimorphic as a result of apoptotic cell death (Sulston and Horvitz, 1977; Sulston et al., 1983) . However, in contrast to the HSNs, the CEMs survive in males and die in hermaphrodites. Again, TRA-1 activity and egl-1 transcriptional control play pivotal roles in determining the hermaphrodite-specific death of the CEMs. Specifically, using a transcriptional reporter, it was shown that egl-1 is expressed in a sex-specific manner in CEMs; expression was detected in the CEMs in wild-type hermaphrodites, but not in masculinized hermaphrodites, in which the CEMs survive in a manner similar to that in males (R Nehme and B Conradt; unpublished observation). (For practical reasons, masculinized hermaphrodites, rather than males, are commonly used for studies on the sexually dimorphic HSN and CEM death.) Furthermore, as in the HSNs, the tra-1 gene acts genetically upstream of egl-1 in the CEMs. However, in contrast to the HSNs, in which tra-1 negatively regulates then egl-1 function to prevent HSN death, in the CEMs, tra-1 promotes the egl-1 function to cause CEM death (B Conradt; unpublished observation). GLI-like transcription factors in other organisms, such as D. melanogaster and mammals, have been shown to act as both repressors and activators of transcription. To determine whether the TRA-1 protein directly activates egl-1 transcription in the CEMs by binding to the TRA-1-binding site downstream of the egl-1 transcription unit, we analysed the survival of the CEMs in egl-1 gf hermaphrodites in which the TRA-1-binding site is disrupted by mutations. We found that the CEMs did not inappropriately survive in these animals, indicating that the TRA-1 protein most probably promotes egl-1 transcription indirectly (P Grote and B Conradt; unpublished observation). Indeed, Bob Horvitz, Ding Xue et al. have recently shown that TRA-1 acts through the BarH homeodomain transcription factor, CEH-30, to promote egl-1 transcription (Figure 3) (Peden et al., 2007; Schwartz and Horvitz, 2007) . Specifically, the transcription of the ceh-30 gene, which was identified as a gene required for the survival of the CEMs in males, is directly repressed by TRA-1 in CEMs. The CEH-30 protein in turn may directly repress egl-1 transcription; however, this remains to be determined experimentally.
The NSM and NSM sister cell: two sisters, one death Unlike the HSNs and CEMs, the neurosecretory motoneuron (NSM) sister cells die in both hermaphrodites and males (Sulston et al., 1983) . The NSM sister cells are generated B400 min after the first cell division and undergo apoptosis B30 min later. In contrast, their sisters, the NSMs, survive and differentiate into serotonergic motoneurons. (There are two NSM lineages, the left and right NSM lineage, which give rise to two NSM sister cells and two NSMs.) Rather than being specified by sex-specific egl-1 expression, the lifeversus-death decision in the case of the NSMs and NSM sister cells is determined by asymmetric egl-1 expression (Thellmann et al., 2003) . Specifically, egl-1 is expressed in the NSM sister cells, which are programed to die, but not in the NSMs, which are programed to survive. Using forward and reverse genetic approaches, two transcription factors have been identified that can control egl-1 transcription in the NSM and NSM sister cell (Ellis and Horvitz, 1991; Metzstein and Horvitz, 1999; Thellmann et al., 2003) . The Snail-like zinc-finger transcription factor, CES-1, can repress egl-1 transcription in the NSM sister cells and thereby prevent their death. Conversely, a heterodimer of the bHLH-transcription factors, HLH-2 and HLH-3 ('HLH-2/HLH-3'), is required for egl-1 transcription in the NSM sister cells. Moreover, reducing HLH-2/HLH-3 activity also prevents their death. It is interesting that both CES-1 and HLH-2/HLH-3 act on egl-1 transcription by binding to four Snail-binding sites/E boxes B3.0 kb Figure 3 Genetic pathway of apoptosis induction and egl-1 regulation during development. The central cell-death pathway as well as cell-specific pathways (HSNs, CEMs, NSMs, P11.aaap and tail-spike cell) are shown.
egl-1: a key activator R Nehme and B Conradt S34 downstream of the stop codon of the egl-1 transcription unit (Thellmann et al., 2003) . Therefore, it has been proposed that CES-1 and HLH-2/HLH-3 antagonize each other's functions by competing for binding to these four Snail-binding sites/E boxes. Interestingly, although HLH-2/HLH-3 is present in both the NSMs and NSM sister cells, the CES-1 protein can only be detected in the NSMs . On the basis of these observations, a model has been proposed in which an asymmetric egl-1 expression in the NSMs and NSM sister cells is a result of the presence of CES-1 in the NSMs and its absence from the NSM sister cells (Figure 4) . Recently, a genetic pathway has been described that functions to restrict the CES-1 protein to the NSMs . This pathway promotes the asymmetric division of the NSM neuroblasts, which give rise to the NSMs and the NSM sister cells. Specifically, the NSM neuroblasts divide asymmetrically to generate two daughter cells of different sizes and fates: the larger NSMs, which are programed to survive, and the smaller NSM sister cells, which are programed to die. The bZIP transcription factor, CES-2, which has prevously been implicated in the NSM sister cell death, and the MIDA-1-like chaperone, DNJ-11, co-operate to repress the transcription of the ces-1 gene in the NSM neuroblasts to cause asymmetric NSM neuroblast division and to restrict the CES-1 protein to the NSM sister cells (Ellis and Horvitz, 1991; Metzstein et al., 1996; Hatzold and Conradt, 2008) . Lf mutations in either the ces-2 or the dnj-11 gene result in higher levels of the CES-1 protein in the NSM neuroblasts. The elevation of the CES-1 level causes symmetric NSM neuroblast division and the generation of two daughter cells of similar sizes, both of which contain quantities of the CES-1 protein that are sufficient to repress egl-1 transcription. Consequently, both daughter cells survive in these mutant backgrounds (Figure 4) . What remains to be determined is how CES-2 and DNJ-11 act to repress ces-1 transcription, how the CES-1 protein affects asymmetric cell division, and how CES-1 itself becomes restricted to the larger NSMs. Possible mechanisms for the latter question include asymmetric segregation of CES-1 to the NSMs and selective proteolysis of CES-1 in the NSM sister cells.
P11.aaap and P12.aaap: turf is critical
During postembryonic development, 12 blast cells (P1-12) in the ventral nerve cord region undergo a series of cell divisions to generate 12 reiterated sublineages along the anterior-posterior body axis of the worm (Sulston and Horvitz, 1977) . The cells P11.aaap (Pn.aaap, the posterior daughter of the anterior daughter of the anterior daughter of the anterior daughter of blast cell, Pn) and P12.aaap (referred to as 'P(11, 12).aaap'), are lineally equivalent to the more anteriorly located cells, P(1-10).aaap; however, P (11, 12) .aaap are programed to die, whereas P(1-10).aaap survive and differentiate into cholinergic motor neurons referred to as VB neurons. Scott Cameron et al. (Liu et al., 2006) found that, in these lineages, the egl-1 expression also correlates with the observed pattern of cell death. Furthermore, they discovered that, in these lineages, Hox genes play an important role in Figure 4 Molecular model of the regulation of the NSM sister cell death. A simplified model is shown.
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Oncogene controlling egl-1 transcription. As in D. melanogaster and vertebrates, C. elegans Hox genes regulate spatial patterning along the anterior-posterior body axis. Mutations in the C. elegans Hox genes, lin-39, mab-5 or egl-5, for instance, affect cell fate specification in specific spatial domains of the ventral nerve cord region, but not in adjacent ones. For example, mutations in the antennapedia-like mab-5 gene cause cell fate specification defects in the sub-lineages derived from blast cells, P11 and P12, but not from blast cells, P1-10 (Kenyon, 1986) . Indeed, Cameron et al. (Liu et al., 2006) found that mab-5 is specifically required for egl-1 expression in P11.aaap and P12.aaap (Liu et al., 2006) . Furthermore, they obtained evidence that, at least in P11.aaap, the MAB-5 protein acts with the Hox co-activator, CEH-20, a member of the extradenticle/PBX TALE class of homeodomain proteins, to directly activate egl-1 transcription. How egl-1 is transcriptionally activated in P12.aaap and how it is repressed in P(1-10).aaap remain to be determined, but Hox genes will most likely play important roles in these processes as well.
The tail-spike cell: taking its time Most cells that are programed to die during C. elegans development do so B30 min after being generated and their deaths are completely dependent not only on ced-4 and ced-3 but also on egl-1 (Horvitz, 2003; Conradt and Xue, 2005) . Furthermore, as discussed above, the transcriptional activation of egl-1 can be regarded as the trigger that leads to apoptosis induction in these cells. In contrast, the tail-spike cell dies B300 min after it is generated, and its death is completely dependent on ced-4 and ced-3, but only partially on egl-1 (Maurer et al., 2007) . (The tail-spike cell is a binucleated cell that may play a role in tail morphogenesis before its programed death.) Specifically, Shai Shaham et al. found that, although lf mutations of ced-4 or ced-3 cause 100% tail-spike cell survival, a lf mutation of egl-1 only causes 30% tail-spike cell survival. In addition, using the transcriptional reporter that was used to analyse egl-1 expression in HSNs, CEMs and NSMs, they were unable to detect egl-1 expression in the tailspike cell. Whether the egl-1 gene is transcriptionally activated in this cell therefore remains to be determined. Interestingly, however, using a transcriptional ced-3 reporter, Shaham et al. (Maurer et al., 2007) found that the ced-3 gene is transcriptionally upregulated in the tail-spike cell just before its death. Furthermore, they identified an activator of ced-3 transcription, the caudaltype homeodomain transcription factor PAL-1, and showed that lf mutations in the pal-1 gene not only reduce ced-3 transcription in the tail-spike cell but also cause tail-spike cell survival (Figure 3) . These findings support a model in which the transcriptional activation of ced-3, rather than of egl-1, or alternatively, the transcriptional activation of both egl-1 and ced-3, acts as the trigger for apoptosis induction. Why would a different mechanism for apoptosis induction be necessary in the case of the tail-spike cell? On the basis of the observations outlined below, we propose that, in contrast to most other cells that are programed to die, proCED-3 levels become limiting in the tail-spike cell before its death, thus making the transcriptional reactivation of the ced-3 gene a necessary event ( Figure 5 ). Using their transcriptional ced-3 reporter, Shaham et al. (Maurer et al., 2007) showed that the ced-3 gene is transcriptionally active in the majority of cells, at least during the wave of cell death that occurs during embryonic development. Interestingly, however, they also found that ced-3 is not transcriptionally active in most cells that are programed to die. This finding indicates that, in most cells programed to die, the proCED-3 protein is derived from ced-3 mRNA that is generated in the precursors of these cells rather than in these cells themselves. As a reminder, with the exception of a few cells (including the tail-spike cell), most cells that are programed to die do so within B30 min of being generated. Therefore, the level of proCED-3 protein derived from the ced-3 mRNA of the precursor must be sufficient for apoptosis induction, if the cell dies within B30 min of being generated. However, as the proCED-3 protein most likely is subject to turn-over, the level of the proCED-3 protein derived from the ced-3 mRNA of the precursor may not be sufficient for apoptosis induction if the cell does not die until B300 min after Simplified models are shown. (a) Most cells that are programed to die during C. elegans development do so within 30 min of being generated. For these cell deaths, the level of proCED-3 that is generated from ced-3 mRNA transcribed in the mother cell is sufficient for EGL-1-dependent apoptosis induction. (b) The tailspike cell dies only 300 min after being generated. To counteract decreasing levels of proCED-3, the ced-3 gene is transcriptionally activated in the tail-spike cell before its death.
egl-1: a key activatorbeing generated, as is the case for the tail-spike cell. The reactivation of ced-3 transcription and the synthesis of additional proCED-3 protein in the tail-spike cell would counteract declining levels of proCED-3 levels derived from the precursor's ced-3 mRNA. Finally, it has been shown earlier that the overexpression of ced-3 can be sufficient for apoptosis induction (Shaham and Horvitz, 1996) . Therefore, the fact that the loss of egl-1 function prevents apoptosis induction in B30% of the tail-spike cells, whereas the loss of ced-3 function prevents apoptosis induction in 100% of the tail-spike cells, indicates that, in B70% of tail-spike cells, the transcriptional reactivation of the ced-3 gene results in levels of the proCED-3 protein that are sufficient for apoptosis induction even in the absence of egl-1 function. In summary, studies on the death of the tail-spike cell indicate that, under pro-caspase-limiting conditions, the transcriptional upregulation of caspase genes can become an important aspect of apoptosis induction.
The role of EGL-1 in germ-cell death
In C. elegans, apoptotic cell death does not only occur in somatic tissues during development but also in the germ line of adult hermaphrodites (Gartner et al., 2008) . Specifically, the majority of germ cells generated in the hermaphrodite germ line are eliminated by apoptotic cell death. Surprisingly, Michael Hengartner et al. (Gumienny et al., 1999) found that this 'constitutive' germ-cell death can be suppressed by ced-9 and is dependent on ced-4 and ced-3, but not on egl-1. How constitutive germ-cell death is triggered in a manner that is completely egl-1-independent remains to be determined, but recent evidence suggests that the transcriptional regulation of components of the central apoptosis machinery (that is, ced-9, ced-4 and ced-3) might play an important role. Helen Chamberlin et al. (Park et al., 2006) found that EGL-38 and PAX-2, C. elegans members of the PAX family of transcription factors, promote the transcription of the ced-9 gene and that their simultaneous loss results in increased constitutive germ-cell death. (The simultaneous loss of the egl-38 and pax-2 function also causes ectopic apoptosis in embryos.) Furthermore, we have recently shown that lf mutations in the genes, lin-35, dpl-1 or efl-1/efl-2, which encode C. elegans orthologs of mammalian RB, DP and E2F, respectively, block B50% of constitutive germ-cell death (Schertel and Conradt, 2007) . In addition, we found that the LIN-35 protein promotes germ-cell apoptosis by repressing ced-9 transcription and that the DPL-1 protein (and, most likely, the proteins EFL-1 and EFL-2 as well) promotes germ-cell apoptosis by enhancing the transcription of ced-4 and ced-3.
The exposure of C. elegans hermaphrodites to certain pathogens (such as Salmonella typhimurium) or to DNA damage-inducing agents causes the apoptotic death of additional germ cells (Gartner et al., 2008) . In contrast to constitutive germ-cell death, pathogen-and DNA damage-induced germ-cell death is not only dependent on ced-4 and ced-3 but also on egl-1. Furthermore, DNA damage-induced germ-cell death is partially dependent on ced-13, a second C. elegans BH3-only gene, which was identified on the basis of its sequence similarity to the egl-1 gene (Schumacher et al., 2005; Stergiou et al., 2007) . (The loss of ced-13 function does not affect apoptotic cell death during development or during constitutive germ-cell death.) Similar to EGL-1, the CED-13 protein can bind to CED-9 and induce apoptosis in a ced-4-and ced-3-dependent manner when overexpressed in embryos (Schumacher et al., 2005) . Why two BH3-only proteins are involved in DNA damage-induced germ-cell death is currently unknown. In addition, although it is currently unclear how EGL-1 activity is controlled in the case of pathogen-induced germ-cell death, Michael Hengartner, Anton Gartner et al. have established that the activities of EGL-1 and CED-13 during DNA damage-induced germ-cell death are controlled at the transcriptional level and that CEP-1, the C. elegans ortholog of mammalian p53, is required for the activation of egl-1 and ced-13 transcription in response to DNA damage (Derry et al., 2001; Schumacher et al., 2001 Schumacher et al., , 2005 Hofmann et al., 2002) .
Non-apoptotic functions of the egl-1 gene?
A number of proteins that were thought to specifically function in apoptosis have recently been found to have non-apoptotic 'day jobs'. For instance, in certain contexts, caspases can play an important role in differentiation, and BAX and BAK have been shown to function in mitochondrial fusion (Woo et al., 2003; Su et al., 2005; Karbowski et al., 2006) . It has been suggested that the EGL-1 protein also acts in mitochondrial dynamics; however, it remains to be determined whether this is indeed an activity of EGL-1, which is relevant in non-apoptotic cells in C. elegans (Jagasia et al., 2005; Delivani et al., 2006) . Furthermore, Kroemer et al. (Maiuri et al., 2007) have proposed that EGL-1 is sufficient to trigger autophagy during embryogenesis. However, their conclusion is mainly based on the observation that the egl-1 gf mutation, n487, causes a general increase in constitutive autophagy as measured by the expression of the gene, lgg-1, the C. elegans ortholog of Atg8/LC3, which is a marker for autophagy. As the n487 mutation causes the inappropriate expression of egl-1 in only two specific cells during embryogenesis, the HSNs (thereby causing their inappropriate death in hermaphrodites), it is unclear whether the effect observed is a direct result of egl-1(n487gf).
Concluding remarks
Evolutionary conservation Similar to mammalian BH3-only proteins, EGL-1 triggers apoptosis induction predominantly by antagonizing egl-1: a key activatorthe function of an anti-apoptotic member of the core BCL-2 family. The mechanism of action of BH3-only proteins is therefore conserved from worms to humans (Labi et al., 2006; Youle and Strasser, 2008) . But what about their regulation? The studies on EGL-1 regulation summarized here, as well as recent studies on the regulation of mammalian BH3-only proteins, strongly suggest that there is also conservation among the mechanisms and pathways that regulate their activities. Similar to the activity of C. elegans EGL-1, the activities of the mammalian BH3-only proteins, NOXA, PUMA and BIM, are largely regulated at the transcriptional level (Labi et al., 2006; Youle and Strasser, 2008) . Furthermore, homologous pathways have been found to control the transcription of the egl-1 gene in C. elegans and the transcription of the genes encoding NOXA and PUMA in mammals. For example, the transcription of NOXA and PUMA in response to DNA damage is induced by the transcription factor, p53 (Oda et al., 2000; Han et al., 2001; Nakano and Vousden, 2001) . Similarly, the transcription of egl-1 in response to DNA damage is induced by the C. elegans ortholog of p53, CEP-1 (Hofmann et al., 2002) . In addition, the transcription of egl-1 in the NSM lineage is controlled by the Snail-like zinc-finger transcription factor, CES-1, the transcription of which in turn is repressed by the bZIP transcription factor, CES-2 (Metzstein et al., 1996; Metzstein and Horvitz, 1999; Thellmann et al., 2003) . Tom Look et al. showed that a homologous pathway acts in the hematopoietic system in mammals to control the transcription of PUMA (Inaba et al., 1996; Inukai et al., 1999; Wu et al., 2005) . Specifically, they found that the CES-1-like zinc-finger transcription factor, SLUG, controls PUMA transcription and that the transcription of SLUG in turn can be controlled by the oncoprotein, E2A-HLF (hepatic leukemia factor), which is composed of the DNA binding domain of the CES-2-like bZIP transcription factor HLF and the transactivation domain of the bHLH transcription factor E2A. Furthermore, mammalian or vertebrate homologs of C. elegans TRA-1 (GLI-like transcription factors) and CEH-30 (Barhl1, Barhl2) have been implicated in apoptosis regulation (Li et al., 2002 Ruiz i Altaba et al., 2002; Offner et al., 2005; Li and Xiang, 2006) . Although the relevant targets of these transcription factors in this context remain to be identified, one prediction is that they will include BH3-only genes.
Control of apoptosis during development
One interesting theme that has emerged from the studies of egl-1 regulation is that the pathways that control egl-1 transcription during development (and hence apoptosis induction during development) do not specifically function in apoptosis regulation, but play additional, crucial roles during development. For instance, the major role of TRA-1, which controls egl-1 transcription in the HSNs and CEMs, is to globally repress male-specific genes in somatic tissues, thereby allowing female development (Zarkower, 2006) . HLH-2 and HLH-3, which are required for the transcriptional activation of egl-1 in NSM sister cells, are also required for embryonic viability and neuronal differentiation, respectively (Krause et al., 1997; Doonan et al., 2008) . Finally, as mentioned above, MAB-5 and CEH-20, which are required for egl-1 transcriptional activation in P11.aaap, also function in spatial patterning along the anterior-posterior body axis (Kenyon, 1986; Liu and Fire, 2000) . The fact that regulators of egl-1 transcription have additional, nonapoptotic functions in development has made the analysis of some of them challenging. In addition, it has made experiments to discern direct from indirect effects even more important.
Apoptosis and tumorigenesis
The mammalian homologs of a number of regulators of egl-1 transcription have been shown to be protooncoproteins or tumor suppressors. For example, mammalian GLI-1 was originally identified as a protooncogene amplified in glioblastomas (Ruiz i Altaba et al., 2002) . The ces-2-like proto-oncogene HLF was identified at the breakpoint of a t(17;19) chromosomal translocation found in patients with pro-B-cell acute lymphoblastic leukemia and the ceh-20-like proto-oncogene PBX-1 was identified at the breakpoint of a t(1;19) chromosomal translocation found in patients with pre-Bcell acute lymphoblastic leukemia (Kamps et al., 1990; Nourse et al., 1990; Hunger et al., 1992; Inaba et al., 1992) . Finally, the CEP-1-like mammalian p53 protein is a tumor suppressor that is found to be inactivated in the majority of human tumors (Pietsch et al., 2008) . These observations show that the deregulation of apoptosis is a critical aspect of tumorigenesis. They also show that the study of apoptosis regulation in organisms such as C. elegans remains an important tool for the identification of novel proto-oncoproteins and tumor suppressors, which represent potential targets for the development of diagnostic tools and anti-tumor therapies. Considering that we have deciphered how the egl-1 transcription is controlled in only eight of the 131 somatic cells that die during the development of a C. elegans hermaphrodite, we will be busy for some time to come.
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